{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:44:48Z","timestamp":1757616288267,"version":"3.44.0"},"reference-count":17,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["K12HS022981"],"award-info":[{"award-number":["K12HS022981"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Sex Reprod Health"],"accepted":{"date-parts":[[2019,9,21]]},"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>First-trimester abortion is widely available in Mexico City since legalisation in 2007, but few data exist surrounding pharmacy staff knowledge and sales practices. We describe misoprostol availability, whether a prescription is required, and knowledge of the legal status of abortion and uses for misoprostol among pharmacy staff in Mexico City.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data were collected from 174 pharmacies in Mexico City. One employee at each pharmacy was asked about availability, need for prescription, indications for misoprostol, and sociodemographic information. Our primary outcome was availability of misoprostol. We used descriptive and bivariate statistics to compare knowledge and practices by type of pharmacy and staff gender.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients and public involvement<\/jats:title>\n                  <jats:p>No patients were involved in this study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 174 pharmacies, 65 were chain and 109 small independent. Misoprostol was available at 61% of sites. Only 49% of independent pharmacies sold misoprostol, compared with 81.5% of chain pharmacies (p&lt;0.05). Knowledge of indications for misoprostol use was similar. The majority (80%) of respondents knew that abortion was legal in Mexico City, and 44% reported requiring a prescription for sale of misoprostol, with no significant difference between male and female staff or by pharmacy type.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Availability, requirement of a prescription, and knowledge of indications for use of misoprostol varies among pharmacies, resulting in differential access to medical abortion. Pharmacies may be a good place to target education for pharmacy staff and women about safe and effective use of misoprostol for abortion.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjsrh-2019-200394","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T17:25:15Z","timestamp":1572974715000},"page":"46-50","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Misoprostol knowledge and distribution in Mexico City after the change in abortion law: a survey of pharmacy staff"],"prefix":"10.1136","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9609-4421","authenticated-orcid":false,"given":"Greta","family":"Weaver","sequence":"first","affiliation":[{"name":"Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaela","family":"Schiavon","sequence":"additional","affiliation":[{"name":"Independent Consultant, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elena","family":"Collado","sequence":"additional","affiliation":[{"name":"Ipas, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2226-6355","authenticated-orcid":false,"given":"Stephanie","family":"K\u00fcng","sequence":"additional","affiliation":[{"name":"Ipas, Durham, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8120-028X","authenticated-orcid":false,"given":"Blair G","family":"Darney","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"key":"2025090510451948000_46.1.46.1","article-title":"Who presents past the gestational age limit for first trimester abortion in the public sector in Mexico City?","volume":"13","author":"Saavedra-Avendano","year":"2018","journal-title":"PLoS One"},{"key":"2025090510451948000_46.1.46.2","article-title":"Quantifying disparities in access to public-sector abortion based on legislative differences within the Mexico City metropolitan area","volume":"99","author":"Friedman","year":"2019","journal-title":"Contraception"},{"key":"2025090510451948000_46.1.46.3","first-page":"159","article-title":"Patient characteristics and service trends following abortion legalization in Mexico City, 2007-10","volume":"42","author":"Mondrag\u00f3n y Kalb","year":"2011","journal-title":"Stud Fam Plann"},{"doi-asserted-by":"publisher","key":"2025090510451948000_46.1.46.4","DOI":"10.2105\/AJPH.2012.301202"},{"key":"2025090510451948000_46.1.46.5","first-page":"127","article-title":"Characteristics of private abortion services in Mexico City after legalization","volume":"18","author":"Schiavon","year":"2010","journal-title":"Reprod Health Matters"},{"unstructured":"Guttmacher Institute . Menstrual regulation and unsafe abortion in Bangladesh. Available: https:\/\/www.guttmacher.org\/fact-sheet\/menstrual-regulation-unsafe-abortion-bangladesh [Accessed 23 Mar 2019].","key":"2025090510451948000_46.1.46.6"},{"key":"2025090510451948000_46.1.46.7","first-page":"445","article-title":"Pharmacy worker practices related to use of misoprostol for abortion in one Mexican state","volume":"79","author":"Billings","year":"2009","journal-title":"Contraception"},{"key":"2025090510451948000_46.1.46.8","first-page":"075","article-title":"How often and under which circumstances do Mexican pharmacy vendors recommend misoprostol to induce an abortion?","volume":"37","author":"Lara","year":"2011","journal-title":"Int Perspect Sex Reprod Health"},{"doi-asserted-by":"publisher","key":"2025090510451948000_46.1.46.9","DOI":"10.1007\/s11096-009-9294-z"},{"key":"2025090510451948000_46.1.46.10","first-page":"57","article-title":"Medical abortion provision by pharmacies and drug sellers in low- and middle-income countries: a systematic review","volume":"49","author":"Footman","year":"2018","journal-title":"Stud Fam Plann"},{"key":"2025090510451948000_46.1.46.11","first-page":"394","article-title":"Pharmacy provision of medical abortifacients in a Latin American city","volume":"74","author":"Lara","year":"2006","journal-title":"Contraception"},{"key":"2025090510451948000_46.1.46.12","first-page":"164","article-title":"Availability and provision of misoprostol and other medicines for menstrual regulation among pharmacies in Bangladesh via mystery client survey","volume":"124","author":"Huda","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"doi-asserted-by":"publisher","key":"2025090510451948000_46.1.46.13","DOI":"10.1136\/jfprhc-2013-100821"},{"key":"2025090510451948000_46.1.46.14","article-title":"Knowledge and provision of misoprostol among pharmacy workers in Senegal: a cross sectional study","volume":"17","author":"Reiss","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025090510451948000_46.1.46.15","first-page":"214","article-title":"Client-pharmacy worker interactions regarding medical abortion in Zambia in 2009 and 2011","volume":"132","author":"Hendrickson","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"2025090510451948000_46.1.46.16","first-page":"116","article-title":"Using a harm reduction lens to examine post-intervention results of medical abortion training among Zambian pharmacists","volume":"22","author":"Fetters","year":"2014","journal-title":"Reprod Health Matters"},{"key":"2025090510451948000_46.1.46.17","first-page":"104","article-title":"Pharmacy workers in Nepal can provide the correct information about using mifepristone and misoprostol to women seeking medication to induce abortion","volume":"22","author":"Tamang","year":"2014","journal-title":"Reprod Health Matters"}],"container-title":["BMJ Sexual &amp; Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjsrh-2019-200394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T18:09:22Z","timestamp":1757095762000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1136\/bmjsrh-2019-200394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,9]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1136\/bmjsrh-2019-200394"],"URL":"https:\/\/doi.org\/10.1136\/bmjsrh-2019-200394","relation":{},"ISSN":["2515-1991","2515-2009"],"issn-type":[{"type":"print","value":"2515-1991"},{"type":"electronic","value":"2515-2009"}],"subject":[],"published":{"date-parts":[[2019,11,5]]}}}